Risk of Recurrent Venous Thromboembolism and Bleeding in Cancer Patients Treated With Direct Oral Anticoagulants Versus Low-molecular-weight Heparin

被引：1

作者：

Long, Brit ^{[1
]}

Koyfman, Alex ^{[2
]}

Gottlieb, Michael ^{[3
]}

机构：

[1] Brooke Army Med Ctr, Dept Emergency Med, Ft Sam Houston, TX 78234 USA

[2] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA

[3] Rush Univ, Med Ctr, Dept Emergency Med, Chicago, IL 60612 USA

来源：

ACADEMIC EMERGENCY MEDICINE | 2020年 / 27卷 / 02期

关键词：

AMERICAN SOCIETY; PROPHYLAXIS; GUIDELINE; DISEASE;

D O I：

10.1111/acem.13855

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：170 / 172

页数：3

共 50 条

[31] Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis
Rungjirajittranon, Tarinee
Owattanapanich, Weerapat
Chinthammitr, Yingyong
Ruchutrakool, Theera
Suwanawiboon, Bundarika
THROMBOSIS JOURNAL, 2022, 20 (01)
[32] Low-molecular-weight heparin for the treatment of venous thromboembolism
Hirsh, J
AMERICAN HEART JOURNAL, 1998, 135 (06) : S336 - S342
[33] LOW-MOLECULAR-WEIGHT HEPARIN TREATMENT OF VENOUS THROMBOEMBOLISM
HULL, RD
PINEO, GF
PROGRESS IN CARDIOVASCULAR DISEASES, 1994, 37 (02) : 71 - 78
[34] Treatment of venous thromboembolism with low-molecular-weight heparin
Hull, RD
Pineo, GF
INTERNATIONAL CONGRESS OF PHLEBOLOGY, 1996, : 269 - 281
[35] Low-molecular-weight heparin in the treatment of venous thromboembolism
Hull, RD
Pineo, GF
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 : 61 - 67
[36] Low-molecular-weight heparin for treating venous thromboembolism
Mahoney, M
Kahn, M
ANNALS OF INTERNAL MEDICINE, 1999, 130 (01) : 77 - 77
[37] Low-molecular-weight heparin therapy for venous thromboembolism
Haas, S
Haas, P
Creutzig, A
VASA-JOURNAL OF VASCULAR DISEASES, 2000, 29 (01): : 5 - 10
[38] Low-molecular-weight heparin for the treatment of venous thromboembolism
Hull, RD
Pineo, GF
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 17 (01) : 65 - 70
[39] Direct acting oral anticoagulants versus low molecular weight heparin for primary thromboprophylaxis in cancer patients
Mendez, Natalia
Norambuena, Constanza
Silva, Symon
Lopez, Valentin
MEDWAVE, 2021, 21 (04):
[40] IDENTIFICATION OF RISK-FACTORS FOR BLEEDING DURING TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM WITH HEPARIN OR LOW-MOLECULAR-WEIGHT HEPARIN
NIEUWENHUIS, HK
ALBADA, J
BANGA, JD
SIXMA, JJ
BLOOD, 1991, 78 (09) : 2337 - 2343

← 1 2 3 4 5 →